Zobrazeno 1 - 10
of 16
pro vyhledávání: ''
Autor:
Daniela A. Bota, Thomas H. Taylor, David E. Piccioni, Christopher M. Duma, Renato V. LaRocca, Santosh Kesari, Jose A. Carrillo, Mehrdad Abedi, Robert D. Aiken, Frank P. K. Hsu, Xiao-Tang Kong, Candace Hsieh, Peter G. Bota, Gabriel I. Nistor, Hans S. Keirstead, Robert O. Dillman
Publikováno v:
Journal of experimental & clinical cancer research : CR, vol 41, iss 1
Background Vaccine immunotherapy may improve survival in Glioblastoma (GBM). A multicenter phase II trial was designed to determine: (1) the success rate of manufacturing the Aivita GBM vaccine (AV-GBM-1), (2) Adverse Events (AE) associated with AV-G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d452687f27f51d3fa6d821c2d61a207
https://doi.org/10.21203/rs.3.rs-2117699/v1
https://doi.org/10.21203/rs.3.rs-2117699/v1
Autor:
Ruggero Ruggieri, Marcello Ceccaroni, Francesco Cuccia, Michele Rigo, Filippo Alongi, Niccolò Giaj-Levra, E. Pastorello, Vanessa Figlia, Francesco Ricchetti, Luca Nicosia, Rosario Mazzola, Claudio Vitale, G. Attinà
BackgroundThe use of stereotactic radiotherapy (SBRT) for oligometastases is supported by several literature studies, but in the setting of gynecological malignancies, this scenario remains quite unexplored. This study reports a preliminary assessmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bfd6772c2cf3663b8fd9c406376ba60
https://doi.org/10.21203/rs.3.rs-809076/v1
https://doi.org/10.21203/rs.3.rs-809076/v1
Autor:
Seiji Hasegawa, Shigeki Yamaguchi, Eiji Shinto, Naohiro Tomita, Megumi Ishiguro, Yasumasa Takii, Kazuo Hase, Hideyuki Ishida, Yojiro Hashiguchi, Eiji Oki, Tetsuya Kusumoto, Shinobu Ohnuma, Mototsugu Shimokawa, Masaru Morita, Heita Ozawa, Masafumi Tanaka, Sachiyo Tada, Tomoko Matsushima, Manabu Shiozawa
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background Adjuvant chemotherapy reduces the risk of recurrence of stage III colon cancer (CC). However, more effective prognostic and predictive biomarkers are needed for better treatment stratification of affected patients. Here, we constructed a 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a80f16a9fa8d66da69492b5f902eba59
https://doi.org/10.21203/rs.3.rs-579197/v1
https://doi.org/10.21203/rs.3.rs-579197/v1
Autor:
Roberta Colombo, Salvatore Alessio Angileri, Emanuele Montanari, Luca Boeri, Gianpiero Cardone, Anna Maria Ierardi, Paola Scagnelli, Gianpaolo Carrafiello, Pierpaolo Biondetti, Maurizio Papa, Gianpaolo Lucignani
Objectives To evaluate the performance of a simplified-ABLATE score (sABLATE) in predicting complications and outcome in respect to RENAL, mRENAL and ABLATE scores. Methods This study included 136 renal lesions in 113 patients (M:F ratio=2.5; mean ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0b2af4e0b0f9460d2d0aafbf07269d9
https://doi.org/10.21203/rs.3.rs-465268/v1
https://doi.org/10.21203/rs.3.rs-465268/v1
Autor:
Wolfram Samlowski, Camille Adajar
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
BMC Cancer
Background Virtually all metastatic patients with metastatic melanoma who progress after initial treatment with PD-1 or CTLA-4 directed antibodies will die of their disease. Salvage options are urgently needed. It is theoretically attractive to combi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30c691373cc71171a0d25033008207d7
https://doi.org/10.21203/rs.3.rs-386981/v1
https://doi.org/10.21203/rs.3.rs-386981/v1
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Background Chimeric antigen-receptor T-cell and bispecific antibody therapies will likely necessitate a reconsideration of the role of autologous stem-cell transplantation (ASCT) in lymphoma. Patients who are likely to profit from ASCT need to be bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57242755ab1e2490a871a3f1f5382631
https://doi.org/10.21203/rs.3.rs-136865/v1
https://doi.org/10.21203/rs.3.rs-136865/v1
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
BMC Cancer
BMC Cancer
Background Liver metastasis is a significant adverse predictor of overall survival (OS) among breast cancer patients. The purpose of this study was to determine the risk and prognostic factors of breast cancer with liver metastases (BCLM). Methods Da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94b396dbdc3ea594e4cf279c87d7ccfa
https://doi.org/10.21203/rs.3.rs-17121/v2
https://doi.org/10.21203/rs.3.rs-17121/v2
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-5 (2021)
BMC Cancer
BMC Cancer
BackgroundTo explore the feasibility of adjuvant surgery following concurrent chemoradiation therapy (CCRT) in stage IIB–IIIB (according to FIGO staging of 2009) cervical cancer and analyze risk factors of recurrence after surgery.MethodsForty-nine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b8c4455f1694fdae0e28dc60383cde5
https://doi.org/10.21203/rs.3.rs-53507/v1
https://doi.org/10.21203/rs.3.rs-53507/v1
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Cancer
BMC Cancer
BackgroundTo evaluate the feasibility and effectiveness of artificial ascites to assist thermal ablation of liver cancer adjacent to the gastrointestinal tract in patients with previous abdominal surgery.MethodsThirty-nine patients with a total of 40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23bb810f6e84d7d4b5fa8532375112a4
https://doi.org/10.21203/rs.3.rs-28248/v2
https://doi.org/10.21203/rs.3.rs-28248/v2
Autor:
Keiya Okamura, Rei Suzuki, Chihiro Sakaguchi, Chigusa Morizane, Hirofumi Shirakawa, Masafumi Ikeda, Kumiko Umemoto, Hiroshi Imaoka, Hiroto Inoue, Junji Furuse, Takeshi Terashima, Hiroaki Nagano, Masato Ozaka, Makoto Ueno, Yasuyuki Kawamoto, Kosuke Maehara, Kazuhiko Shioji, Satoshi Kobayashi, Kunihiro Tsuji
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Background Undifferentiated carcinoma (UC) of the pancreas is a rare subtype of pancreatic cancer. Although UC has been considered a highly aggressive malignancy, no clinical studies have addressed the efficacy of chemotherapy for unresectable UC. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91f9f11a5ef05c1f4311c0fb0a6f30f2
https://doi.org/10.21203/rs.3.rs-42675/v1
https://doi.org/10.21203/rs.3.rs-42675/v1